SAO PAULO (Reuters) – Brazilian health regulator Anvisa has authorized resumption of a clinical trial with Janssen-Cilag Farmacêutica Ltda’s potential COVID-19 vaccine, according to a statement from the government agency on Tuesday.
The company is a unit of Johnson & Johnson . Its vaccine prototype is one of four vaccines being tested in Brazil.
(Reporting by Anthony Boadle and Ana Mano)
